NCT04250922: LAM561 With RT and TMZ for Adults With Glioblastoma
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 144 taking part
- Started
- 1 Dec 2019
- Primary completion
- 15 Jan 2026
- Arms
- Arm B: SoC + 12 g/day of LAM561
- Results
- None posted
- 1 Dec 2019: Trial started
- 31 Jan 2020: Trial registered